Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Granisetron vs Ondansetron for Pediatric Gastroenteritis
NCT06175806Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of granisetron in gastroenteritis (2 arms), sponsored by Ain Shams University. Primary endpoint: Effectiveness of treatment on vomiting frequency at 48 hours. Started Sep 2023; status: completed.
02
Drugs
granisetron
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on NCT06175806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06175806.